A Food and Drug Administration advisory committee recommended approval of EnteroMedics Inc.'s (Nasdaq: ETRM) obesity treatment VBLOC Therapy sending the stock price up 21 cents to $1.73.
FDA committee recommends EnteroMedics' VBLOC
June 18, 2014 at 13:06 PM EDT
